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Her present address is The Animal Medical Center, 510 East 62nd Street, New York, NY 10021. 
Introduction 
Euthanasia means, according to its 
Greek root, an "easy death" (17) and is, 
by definition the act of inducing death 
without pain (19). To a Doctor of Veteri-
nary Medicine, trained in the healing art, 
the idea of euthanizing is not pleasant. 
However, millions of unwanted dogs and 
cats are brought to the public and pri-
vate animal shelters annually, and the 
most humane disposition of these animals 
is to give them a "good death." 
This entails an enormous ethical re-
sponsibility and the moral injunction 
that the method of killing be humane 
(causing the least possible distress, 
physically and psychologically). There-
fore, there is an obligation, as a final 
ethical responsibility and demonstration 
of respect for the life that is to be ter-
minated, to utilize the best available 
method of euthanasia: to induce a gentle 
and painless death without causing fear, 
stress, anxiety or suffering (21 ). 
The tools of evaluating the degree 
of distress in animals being killed in-
clude electroencephalography (EEG), elec-
trocardiography (ECG), and measurement 
of blood pressure and respiration. Sound 
clinical and behavioral observations 
should also not be abandoned in the 
eva I uation process (21 ). 
There are many methods which may 
be employed to reach the same end re-
su Its, but the ideal method should satis-
fy several criteria (20): 
1. It should be painless; 
2. It should cause unconsciousness 
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instantaneously and death within minutes; 
3. It should not cause undue anxi-
ety, alarm, fear, panic, behavior, strug-
gling, vocalization, muscle spasms or 
clinical signs of automatic activation 
(e.g., convulsions) before unconsciousness; 
4. It should always cause death when 
properly used; 
5. It should be safe for the properly 
trained person to use; 
6. It should be easy for the properly 
trained person to use; 
7. It should not be a drug subject 
to abuse in human beings; 
B. It should be aesthetically unob-
jectionable. (This criterion depends on 
who the observers are); 
9. It should be practical to use for 
the particular type of animal to be killed; 
10. It should not create a problem 
of sanitation or environmental contami-
nation; 
11. It should not cause tissue changes 
which will alter postmortem examina-
tion or chemical tests; and 
12. It should be economical. 
The objective of this paper is to 
review the literature on the use ofT -61 * 
as an euthanasic agent and to determine 
to what extent it meets the above crite-
ria. 
Early Use of T-61 
The use of T-61 solution for killing 
small animals was first reported in West 
*Hoechst-Roussel Pharmaceuticals, Inc. Somerville, NJ. USA. 
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Germany by Fikmeier in 1962 (5) and for 
killing large animals by Kuepper in 1964 
(10). Fikmeier concluded after killing 350 
dogs and 300 cats that the material was 
very suitable for euthanasia. Its use in 
private practice has spread in some coun-
tries. In Italy, under the trade name 
"Tanax," this material is being widely used 
to kill unwanted animals in municipal 
animal pounds (21). In the United States, 
its clinical use in small animals was first 
reported by Quin in 1963 (16). 
The Agent 
T -61 is an injectable non barbiturate 
solution that consists of a mixture of 
three agents (3). Each milliliter contains: 
1. 200 mg of N-[2-(m-methoxy-
phenyl) 2-ethyl-butyl-(1 )]-gamma-hy-
droxybutyramide, having a strong narcotic 
effect on the central nervous system, 
where it also paralyzes the brain center 
controlling respiration; 
2. 50 mg of 4.4-methylene-bis (cy-
clohexyl-trimethyl-ammonium iodide), 
which exerts a paralytic action on 
striated muscle and rapidly induces cir-
culatory collapse (curariform-like action)*; 
3. 5 mg of tetracaine hydrochloride, 
which is a local anesthetic added to 
reduce painful tissue reactions at the 
site of injection; with 0.6 ml of dimethyl-
formam ide in distilled water. 
The manufacturers (3) recommend 
that, in dogs the injection should prefer-
ably be given intravenously. Intrapulmo-
nary or intracardiac injections may be 
given where the intravenous injection is 
impractical, as in very small dogs and 
cats, or in a comatose animal with de-
pressed vascular function. With the in-
trapulmonary route, care should be 
taken not to displace the lung tissue and 
inject into the pleural cavity. In cats the 
intrapulmonary route is considered by 
*The curare-like drug is included to control seizures which may be 
triggered by the narcotic compound According to one company's 
veterinary representative, it insures that "if the antmal were to re-
gam consciousness, it would die anyway from respiratory arrest," 
i.e. suffocation (21) 
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the manufacturers to be the most practi-
cable method (3). Intramuscular or sub-
cutaneous injections are contraindicated. 
T -61 is exclusively intended for the 
humane euthanasia of dogs, cats, mink, 
horses, laboratory animals (such as rats, 
mice, guinea pigs and rabbits), and birds 
such as pigeons and parakeets (3). 
Two-thirds (2/3) of the total dose 
should be administered without inter-
ruption at the moderate rate of 1 ml 
each 5 seconds. The remaining one-third 
(1/3) may be administered rapidly. The 
correct injection technique is essential 
to effect euthanasia without excitation 
or pain because, when given too rapidly, 
transient anxiety and struggling may oc-
cur before unconsciousness (3). 
The manufacturers (3) recommend 
that one should never overdose an ani-
mal with T -61, as this may lead to over-
excitement and/or convulsions. 
Effect on the Body 
Euthanasia results from central ner-
vous system depression, hypoxia and cir-
culatory collapse. The AVMA Panel on 
Euthanasia (19) describes the drug as act-
ing via a direct depression of the cerebral 
cortex, subcortical structures, vital centers 
and heart muscle. The ultimate cause of 
death is hypoxia and respiration ceases 
due to depression of vital centers and 
muscle paralysis. 
A comparative study of T -61 and 
pentobarbital* indicated that either agent 
induced euthanasia smoothly and with-
out undesirable reactions when properly 
administered (12, 13). The dogs given 
pentobarbital received a total dose of 
57.1 mg/kg of body weight continuously 
at a rate of 1.2 ml/second. The dogs 
given T -61 received two-thirds of the 
total dose (0.3 ml/kg of body weight) at a 
rate of 0.2 m I/ second with the last one-
third given at 1.2 ml/second. 
With both pentobarbital and T -61, 
the electroencephalogram changed from 
*Sodium Pentobarbtta!. USP 129.6 mg/ml. 
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a normal awake pattern to one of low 
frequency and increased amplitude for 
approximately 5 seconds followed quickly 
by electrical silence. The pentobarbi-
tal-treated dogs required 12 seconds 
longer for the occurrence of electrical 
silence. With both agents, alterations in 
electrocardiogram developed immediately 
and arterial pressure dropped to zero. 
However, three pentobarbital-treated 
dogs resumed an effective cardiac out-
put and respiration. Analysis of the res-
piratory response from the start of injec-
tion until initial arrest indicated no sig-
nificant difference between the two 
agents. Results of this study indicated 
that painless death is produced by pen-
tobarbital or T -61 (12, 13, 19). 
Dehner, cited by Quin (16), has 
stated: "For dogs, intravenous applica-
tion of T -61 is the method of choice. 
The lethal effect frequently occurs even 
during the injection, otherwise, directly 
after this procedure. The animal col-
lapses, muscular tonus dies away, and 
breathing stops. In the predominant 
number of cases, the animals die with no 
reaction of any kind, without resistant 
movements, outcrying, or shortness of 
breath. In rare instances where resistant 
movements occur, they persist only a 
few seconds. Ordinarily cardiac activity 
continues for a few seconds after breath-
ing has stopped but rarely for as much as 
a minute." 
Comparison of T-61 With 
Pentobarbital According to Criteria 
for the Ideal Method 
As stated earlier, the ideal method 
for euthanizing animals should satisfy 
the following criteria: 
1. It should be painless. 
The manufacturers have added te-
tracaine hydrochloride, a local anesthetic, 
to T-61 solution to reduce painful tissue 
reactions at the site of injection. Wills 
(23) has found that injecting T -61 in-
travenously in the rear-leg of small cats 
338 
is very effective and painless ("about 
100%"). However, McMurry (15) objects 
to the use of T -61 as an agent for eutha-
nizing animals because of apparent se-
vere pain upon injection. He states that 
tetracaine does not eliminate pain. 
When given intravenously as per instruc-
tions, there was obvious pain in 25 to 
35% of the dogs euthanized (approxi-
mately 500) using T -61. He found that 
many of the dogs whine and/or howl. He 
also declares that if any of the material 
is injected perivascular, which can occur 
when encountering a highly excited ani-
mal, especially when injected by inexper-
ienced personnel, the evidence of pain is 
very obvious. 
Fox (7, 8), has likewise declared that 
even with the addition of the local anes-
thetic ingredient, pain reactions can be 
marked in some animals and may cause 
considerable excitation and distress. 
2. It should cause unconsciousness in-
stantaneously and death within minutes. 
An appropriate technique for eval-
uating unconsciousness is electroence-
phalography (E E G). Up to 197 4, there ap-
peared to be no reported work giving 
E E G data from test cases of T -61 eutha-
nasia. However, Rowsell investigated the 
use of T -61 for euthanasia in a rat and 
determined that the EEG became iso-
electric (flat) within 4 seconds (21 ). 
In 1978, Lumb (12) conducted EEG 
measurements in 21 dogs which indicated 
that T -61 rapidly (within 5 seconds) in-
duced an isoelectric state indicating un-
consciousness. These two studies, on 
one rat and 21 dogs, do not constitute suf-
ficient proof that T -61 is effective in pro-
ducing instantaneous unconsciousness 
in dogs, cats, horses, mink, laboratory 
animals and birds (as the manufacturers 
claim). 
There is much conflicting anecdotal 
evidence on the efficacy ofT -61. Wills 
(23) reported that intravenous injections 
of T -61 into the rear-leg of small cats 
is ... "very effective because complete 
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unconsciousness occurs in 2 to 4 sec-
onds and brain death in 10 to 20 seconds, 
whereas heart and motor functions cease 
in 20 to 30 seconds." However, no spe-
cialized apparatus to measure time of 
unconsciousness, brain death and heart 
and motor functions was used. 
The Executive Director of the Ani-
mal Shelter in Alexandria, Virginia (4), 
objects to the use ofT -61 for euthanasia 
under any circumstances because of the 
pain factor which, as reported by McMurry 
(15), affected one-quarter of the dogs 
that he euthanized with T -61 (according 
to the procedure recommended by the .. 
manufacturers). 
3. It should not cause undue anxiety, 
alarm, fear, panic, behavior, struggling, 
vocalization, muscle spasms or clinical 
signs of activation {e.g. convulsions) be-
fore unconsciousness. 
Stonehouse (22) says that studies 
have shown that T -61 given intravenous-
ly, does not produce any initial curariform 
or muscle relaxant action before central 
nervous system depression occurs. Nev-
ertheless, there are doubts. 
Baker (1) reports that T -61 was with-
drawn in England because animals eu-
thanized with this product exhibited dis-
tress, pain and convu Is ions prior to death. 
Baker noted that the "induction stage, 
anesthetic stage and respiratory paraly-
sis do not occur in that order and ani-
mals tend to get respiratory paralysis 
prior to complete anesthesia." 
McMurry (15) also objects to the 
use of T -61 as an euthanizing agent be-
cause respiration does not always cease 
immediately and the heart continues to 
beat for several minutes following the 
recommended lethal dose. 
There are also doubts about wheth-
er the paralyzing effects of the cur-
are-like compound in T -61 occur before 
unconsciousness sets in. Like many curari-
form drugs, it may cause transient mus-
cular tremors (depolarization) prior to 
unconsciousness (21 ), but it is not known 
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how distressing this may be to animals 
(8, 15). 
In contrast, the use of intravenous 
sodium pentobarbital has been shown to 
cause unconsciousness within the first 
seconds of injection, without any signs 
of distress or pain, or convulsions and 
howling (19). 
There are also doubts about using 
T -61 by intracardiac or intrapulmonary 
routes, as recommended by the manu-
facturers (3), because of possible adverse 
reactions. For example, in the intra-
pulmonary route fluids in the lungs may 
cause significant distress and coughing 
prior to unconsciousness, and the intra-
cardiac route is painful since the peri-
cardium can be very sensitive to the 
needle (7). 
With respect to the intraperitoneal 
route, the manufacturers recommend its 
use in mink but this is contraindicated. 
Uptake by this route is extremely slow 
and seizures may occur. In one study 
(16), three cats were given T -61 by intra-
peritoneal injection. They suffered spasms, 
excitement, a reflex bowel movement 
and dyspnea for 3 to 13 minutes before 
complete collapse. 
Fogle (6) has noted in a letter that 
some veterinarians have stopped the use 
of T -61 because they felt it was not as 
humane as barbiturate intravenously. 
He declared that its main attraction was 
that it eliminated the "last gasp" that 
occurs with some dogs when they are 
euthanized with a barbiturate. This is 
hardly a suitable justification for an eu-
thanasic agent. 
In the study by Lumb (12), compar-
ing T -61 and sodium pentobarbital for 
euthanasia, he notes that: "In most 
respects the effects of the two agents 
were similar; however, 3 of 12 dogs 
given pentobarbital resumed respiration 
and cardiac function. None of the 9 dogs 
given T -61 evidenced signs of recovery." 
He then argues that (13): "On a com-
parative basis T -61 is superior to double-
strength pentobarbital, in that the latter 
339 
L.D. Barocio- Use ofT -61 as an Euthanasic Agent Review Article 
a normal awake pattern to one of low 
frequency and increased amplitude for 
approximately 5 seconds followed quickly 
by electrical silence. The pentobarbi-
tal-treated dogs required 12 seconds 
longer for the occurrence of electrical 
silence. With both agents, alterations in 
electrocardiogram developed immediately 
and arterial pressure dropped to zero. 
However, three pentobarbital-treated 
dogs resumed an effective cardiac out-
put and respiration. Analysis of the res-
piratory response from the start of injec-
tion until initial arrest indicated no sig-
nificant difference between the two 
agents. Results of this study indicated 
that painless death is produced by pen-
tobarbital or T -61 (12, 13, 19). 
Dehner, cited by Quin (16), has 
stated: "For dogs, intravenous applica-
tion of T -61 is the method of choice. 
The lethal effect frequently occurs even 
during the injection, otherwise, directly 
after this procedure. The animal col-
lapses, muscular tonus dies away, and 
breathing stops. In the predominant 
number of cases, the animals die with no 
reaction of any kind, without resistant 
movements, outcrying, or shortness of 
breath. In rare instances where resistant 
movements occur, they persist only a 
few seconds. Ordinarily cardiac activity 
continues for a few seconds after breath-
ing has stopped but rarely for as much as 
a minute." 
Comparison of T-61 With 
Pentobarbital According to Criteria 
for the Ideal Method 
As stated earlier, the ideal method 
for euthanizing animals should satisfy 
the following criteria: 
1. It should be painless. 
The manufacturers have added te-
tracaine hydrochloride, a local anesthetic, 
to T-61 solution to reduce painful tissue 
reactions at the site of injection. Wills 
(23) has found that injecting T -61 in-
travenously in the rear-leg of small cats 
338 
is very effective and painless ("about 
100%"). However, McMurry (15) objects 
to the use of T -61 as an agent for eutha-
nizing animals because of apparent se-
vere pain upon injection. He states that 
tetracaine does not eliminate pain. 
When given intravenously as per instruc-
tions, there was obvious pain in 25 to 
35% of the dogs euthanized (approxi-
mately 500) using T -61. He found that 
many of the dogs whine and/or howl. He 
also declares that if any of the material 
is injected perivascular, which can occur 
when encountering a highly excited ani-
mal, especially when injected by inexper-
ienced personnel, the evidence of pain is 
very obvious. 
Fox (7, 8), has likewise declared that 
even with the addition of the local anes-
thetic ingredient, pain reactions can be 
marked in some animals and may cause 
considerable excitation and distress. 
2. It should cause unconsciousness in-
stantaneously and death within minutes. 
An appropriate technique for eval-
uating unconsciousness is electroence-
phalography (E E G). Up to 197 4, there ap-
peared to be no reported work giving 
E E G data from test cases of T -61 eutha-
nasia. However, Rowsell investigated the 
use of T -61 for euthanasia in a rat and 
determined that the EEG became iso-
electric (flat) within 4 seconds (21 ). 
In 1978, Lumb (12) conducted EEG 
measurements in 21 dogs which indicated 
that T -61 rapidly (within 5 seconds) in-
duced an isoelectric state indicating un-
consciousness. These two studies, on 
one rat and 21 dogs, do not constitute suf-
ficient proof that T -61 is effective in pro-
ducing instantaneous unconsciousness 
in dogs, cats, horses, mink, laboratory 
animals and birds (as the manufacturers 
claim). 
There is much conflicting anecdotal 
evidence on the efficacy ofT -61. Wills 
(23) reported that intravenous injections 
of T -61 into the rear-leg of small cats 
is ... "very effective because complete 
/NT I STUD ANIM PROB 4(4) 1983 
L.D. Barocio- Use of T-61 as an Euthanasic Agent Review Article 
unconsciousness occurs in 2 to 4 sec-
onds and brain death in 10 to 20 seconds, 
whereas heart and motor functions cease 
in 20 to 30 seconds." However, no spe-
cialized apparatus to measure time of 
unconsciousness, brain death and heart 
and motor functions was used. 
The Executive Director of the Ani-
mal Shelter in Alexandria, Virginia (4), 
objects to the use ofT -61 for euthanasia 
under any circumstances because of the 
pain factor which, as reported by McMurry 
(15), affected one-quarter of the dogs 
that he euthanized with T -61 (according 
to the procedure recommended by the .. 
manufacturers). 
3. It should not cause undue anxiety, 
alarm, fear, panic, behavior, struggling, 
vocalization, muscle spasms or clinical 
signs of activation {e.g. convulsions) be-
fore unconsciousness. 
Stonehouse (22) says that studies 
have shown that T -61 given intravenous-
ly, does not produce any initial curariform 
or muscle relaxant action before central 
nervous system depression occurs. Nev-
ertheless, there are doubts. 
Baker (1) reports that T -61 was with-
drawn in England because animals eu-
thanized with this product exhibited dis-
tress, pain and convu Is ions prior to death. 
Baker noted that the "induction stage, 
anesthetic stage and respiratory paraly-
sis do not occur in that order and ani-
mals tend to get respiratory paralysis 
prior to complete anesthesia." 
McMurry (15) also objects to the 
use of T -61 as an euthanizing agent be-
cause respiration does not always cease 
immediately and the heart continues to 
beat for several minutes following the 
recommended lethal dose. 
There are also doubts about wheth-
er the paralyzing effects of the cur-
are-like compound in T -61 occur before 
unconsciousness sets in. Like many curari-
form drugs, it may cause transient mus-
cular tremors (depolarization) prior to 
unconsciousness (21 ), but it is not known 
/NT I STUD ANIM PROB 4(4) 1983 
how distressing this may be to animals 
(8, 15). 
In contrast, the use of intravenous 
sodium pentobarbital has been shown to 
cause unconsciousness within the first 
seconds of injection, without any signs 
of distress or pain, or convulsions and 
howling (19). 
There are also doubts about using 
T -61 by intracardiac or intrapulmonary 
routes, as recommended by the manu-
facturers (3), because of possible adverse 
reactions. For example, in the intra-
pulmonary route fluids in the lungs may 
cause significant distress and coughing 
prior to unconsciousness, and the intra-
cardiac route is painful since the peri-
cardium can be very sensitive to the 
needle (7). 
With respect to the intraperitoneal 
route, the manufacturers recommend its 
use in mink but this is contraindicated. 
Uptake by this route is extremely slow 
and seizures may occur. In one study 
(16), three cats were given T -61 by intra-
peritoneal injection. They suffered spasms, 
excitement, a reflex bowel movement 
and dyspnea for 3 to 13 minutes before 
complete collapse. 
Fogle (6) has noted in a letter that 
some veterinarians have stopped the use 
of T -61 because they felt it was not as 
humane as barbiturate intravenously. 
He declared that its main attraction was 
that it eliminated the "last gasp" that 
occurs with some dogs when they are 
euthanized with a barbiturate. This is 
hardly a suitable justification for an eu-
thanasic agent. 
In the study by Lumb (12), compar-
ing T -61 and sodium pentobarbital for 
euthanasia, he notes that: "In most 
respects the effects of the two agents 
were similar; however, 3 of 12 dogs 
given pentobarbital resumed respiration 
and cardiac function. None of the 9 dogs 
given T -61 evidenced signs of recovery." 
He then argues that (13): "On a com-
parative basis T -61 is superior to double-
strength pentobarbital, in that the latter 
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may not produce lasting cardiac and res-
piratory arrest." 
However, Reilly (18) states that Lumb 
used a dose of pentobarbital sodium 
which was close to the minimum lethal 
dosage, which is no reason, to imply as 
Lumb did, that T -61 is superior to sodium 
pentobarbital. Furthermore, the pentobar-
bital solution was far weaker (130 mg/ml). 
Reilly argues that this is the reason why 
some of the dogs resumed cardiac func-
tion and respiration. 
4. It should always cause death when 
properly used. 
There are numerous agents that can 
cause death, but in the case ofT -61, "it 
is a lethal drug that causes death but not 
necessarily euthanasia" (15). 
5. It should be safe for the properly 
trained person to use. 
The drug is marketed as a vial 
which reduces any possibility of human 
ingestion. However, if T -61 is inadver-
tently taken orally by humans it will be 
absorbed very slowly and the onset ef-
fect will be delayed. Therefore, there 
should be enough time after inadvertent 
swallowing to remove the drug from the 
stomach, thereby preventing serious poi-
soning (9). 
If small amounts of T -61 inadver-
tently get into a wound or under the skin 
of a person injecting it to a struggling 
animal, there is no danger of toxicity (9). 
However, Fogle (6) reported that in Eng-
land, in the early 70's, there was a flurry 
of correspondence to the Veterinary Rec-
ord concerning possible dangers to the 
operator in the use of the drug because 
of its curare-like effect. However, the 
indications are that it is as safe, or safer, 
than many other euthanasic agents. 
6. It should be easy for the properly 
trained person to use. 
Wills (23) declared in a letter that 
injecting T -61 intravenously in the rear-
leg of small cats "is easy to learn, requir-
ing only small degree of medical know!-
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edge." But intravenous injections are 
not easy, even for properly trained per-
sons. In addition, cats are hard to handle, 
which will make it more difficult to find 
a vein in the rear-leg. An advantage of 
sodium pentobartibal overT -61 for cats 
is that it can be given intraperitoneally; 
T -61 cannot. Also, cerebral excitation 
may occur if this drug is not injected ac-
cording to the manufacturer's instruc-
tions (3) ("give the first two-thirds at a 
smooth rate of 1 m I per 5 seconds and 
then the rest rapidly"). Therefore, this 
compound will not be easy to adminis-
ter and even experienced personnel can 
be expected to make mistakes, especial-
ly with nervous, struggling animals. 
As stated before, no euthanizing 
drug should ever be given intrathoraci-
cally because of its inhumaneness, but 
in such cases where it is required to give 
T -61 via the intracardiac route, it is 
necessary that the administrator must be 
experienced and 100% confident of en-
tering the heart every time (21 ). 
Injection of sodium pentobarbital 
is easier than T -61 because it can be ad-
ministered by several routes and the in-
jection rate is not a critical factor. 
7. It should not be a drug subject to 
abuse in human beings. 
T -61 is not classified as a restricted 
drug by the Bureau of Veterinary Medi-
cine of the Food and Drug Administra-
tion of the U.S. (11 ). However, its use is 
only permitted under veterinary supervi-
sion. By constrast, sodium pentobarbital 
is a schedule II drug and its use is close-
ly regulated (11). 
8. It should be aesthetically unobjec-
tionable. {This criterion depends on who 
the observers are.) 
When circumstances require the 
pet's owner to be present during the pro-
cedure, one must assure a smooth, rapid 
and obviously painless, euthanasia. Ac-
cording to reports, T -61 administration 
can be accompanied by agitation, anxi-
ety and spasmodic body movements. So-
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dium pentobarbital can also produce dis-
tressing body spasms (the so-called "last 
gasp"). 
9. It should be practical to use for the 
particular type of animal to be killed. 
A certain proportion of the animals 
that are turned into shelters are in very 
poor condition. They may be injured, 
moribund or diseased. Under these cir-
cumstances T -61 cannot be used be-
cause the absorption and uptake of the 
compound may be delayed. Death is 
protracted with distressing convulsions 
and premature respiratory paralysis be-
fore narcotic unconsciousness can oc-
cur (7, 21 ). Therefore, T -61 is not an ap-
propriate agent for euthanasia of these 
cases. 
10. It should not create a problem of 
sanitation or environmental contamination. 
T -61 and sodium pentobartital do 
not have these kinds of problems; how-
ever, these two agents should not be in-
jected into food animals designated for 
human or animal consumption. 
11. It should not cause tissue changes 
which will alter postmortem examination 
or chemical tests. 
When T -61 is given at larger than 
recommended doses, pulmonary edema 
and other tissue lesions may be produced 
(19). 
12. It should be economical. 
In comparison with sodium pento-
bartital, T -61 is a relatively expensive 
agent according to the information in 
Table I. 
Conclusion 
The available evidence indicates 
that there are many questions about 
T -61 as a satisfactory euthanasic agent. 
The only controlled study of animal E EG's 
after T -61 administration indicated that 
this compound could produce rapid un-
consciousness. However, the drug was 
administered via an indwelling catheter, 
hardly the type of condition to be found 
in a shelter euthanizing 10 to 20 thousand 
animals a year. Furthermore, the investi-
gator compared the T -61 results with 
the results of a weak and marginally 
lethal dose of sodium pentobarbital. 
TABLE 1 Comparative Cost$ ofT-61 and Sodit~m Pentobarbital 
Unit Price Approx. Price 
Product Class* (1 bottle) Unit Price** (per 250 ml) 
T -61 Not schedule 50 ml $13.60 $68.00 
250 ml $55.00 $55.00 
Fatal-Plus 
a 
C-11 250 ml $14.00 $14.00 
Euthanasia-6 b C-11 100 ml $ 7.40 $18.50 
250 ml $14.40 $14.40 
Beuthanasia-Dc C-111 100 ml $22.50 $56.25 
a. Vortech Pharmaceuticals Limited, Dearborn, MI. Each milliliter contains: 390 mg of sodium pentobarbi-
tal (powder reconstituted with ordinary water) 
b. Veterinary Laboratories, Inc., Lenexa, KS. Each milliliter contains: 390 mg of sodium pentobarbital in an 
aqueous alcohol-propylene glycol base. 
c. Burns-Biotec Laboratories, Inc., Omaha, NE. Each milliliter contains: 390 mg of sodium pentobarbital, 
50 mg of phenytoin sodium, 10% of ethyl alcohol, 18% of propylene glycol, 0.003688 mg of rhodamine B 
(coloring) and 2% of benzil alcohol (preservative). 
*Classification of a restricted drug by the Bureau of Veterinary Medicine of the Food and Drug Administra-
tion of the U.S. (11) 
**These prices were obtained from the manufacturers. 
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may not produce lasting cardiac and res-
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Reilly argues that this is the reason why 
some of the dogs resumed cardiac func-
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4. It should always cause death when 
properly used. 
There are numerous agents that can 
cause death, but in the case ofT -61, "it 
is a lethal drug that causes death but not 
necessarily euthanasia" (15). 
5. It should be safe for the properly 
trained person to use. 
The drug is marketed as a vial 
which reduces any possibility of human 
ingestion. However, if T -61 is inadver-
tently taken orally by humans it will be 
absorbed very slowly and the onset ef-
fect will be delayed. Therefore, there 
should be enough time after inadvertent 
swallowing to remove the drug from the 
stomach, thereby preventing serious poi-
soning (9). 
If small amounts of T -61 inadver-
tently get into a wound or under the skin 
of a person injecting it to a struggling 
animal, there is no danger of toxicity (9). 
However, Fogle (6) reported that in Eng-
land, in the early 70's, there was a flurry 
of correspondence to the Veterinary Rec-
ord concerning possible dangers to the 
operator in the use of the drug because 
of its curare-like effect. However, the 
indications are that it is as safe, or safer, 
than many other euthanasic agents. 
6. It should be easy for the properly 
trained person to use. 
Wills (23) declared in a letter that 
injecting T -61 intravenously in the rear-
leg of small cats "is easy to learn, requir-
ing only small degree of medical know!-
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edge." But intravenous injections are 
not easy, even for properly trained per-
sons. In addition, cats are hard to handle, 
which will make it more difficult to find 
a vein in the rear-leg. An advantage of 
sodium pentobartibal overT -61 for cats 
is that it can be given intraperitoneally; 
T -61 cannot. Also, cerebral excitation 
may occur if this drug is not injected ac-
cording to the manufacturer's instruc-
tions (3) ("give the first two-thirds at a 
smooth rate of 1 m I per 5 seconds and 
then the rest rapidly"). Therefore, this 
compound will not be easy to adminis-
ter and even experienced personnel can 
be expected to make mistakes, especial-
ly with nervous, struggling animals. 
As stated before, no euthanizing 
drug should ever be given intrathoraci-
cally because of its inhumaneness, but 
in such cases where it is required to give 
T -61 via the intracardiac route, it is 
necessary that the administrator must be 
experienced and 100% confident of en-
tering the heart every time (21 ). 
Injection of sodium pentobarbital 
is easier than T -61 because it can be ad-
ministered by several routes and the in-
jection rate is not a critical factor. 
7. It should not be a drug subject to 
abuse in human beings. 
T -61 is not classified as a restricted 
drug by the Bureau of Veterinary Medi-
cine of the Food and Drug Administra-
tion of the U.S. (11 ). However, its use is 
only permitted under veterinary supervi-
sion. By constrast, sodium pentobarbital 
is a schedule II drug and its use is close-
ly regulated (11). 
8. It should be aesthetically unobjec-
tionable. {This criterion depends on who 
the observers are.) 
When circumstances require the 
pet's owner to be present during the pro-
cedure, one must assure a smooth, rapid 
and obviously painless, euthanasia. Ac-
cording to reports, T -61 administration 
can be accompanied by agitation, anxi-
ety and spasmodic body movements. So-
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dium pentobarbital can also produce dis-
tressing body spasms (the so-called "last 
gasp"). 
9. It should be practical to use for the 
particular type of animal to be killed. 
A certain proportion of the animals 
that are turned into shelters are in very 
poor condition. They may be injured, 
moribund or diseased. Under these cir-
cumstances T -61 cannot be used be-
cause the absorption and uptake of the 
compound may be delayed. Death is 
protracted with distressing convulsions 
and premature respiratory paralysis be-
fore narcotic unconsciousness can oc-
cur (7, 21 ). Therefore, T -61 is not an ap-
propriate agent for euthanasia of these 
cases. 
10. It should not create a problem of 
sanitation or environmental contamination. 
T -61 and sodium pentobartital do 
not have these kinds of problems; how-
ever, these two agents should not be in-
jected into food animals designated for 
human or animal consumption. 
11. It should not cause tissue changes 
which will alter postmortem examination 
or chemical tests. 
When T -61 is given at larger than 
recommended doses, pulmonary edema 
and other tissue lesions may be produced 
(19). 
12. It should be economical. 
In comparison with sodium pento-
bartital, T -61 is a relatively expensive 
agent according to the information in 
Table I. 
Conclusion 
The available evidence indicates 
that there are many questions about 
T -61 as a satisfactory euthanasic agent. 
The only controlled study of animal E EG's 
after T -61 administration indicated that 
this compound could produce rapid un-
consciousness. However, the drug was 
administered via an indwelling catheter, 
hardly the type of condition to be found 
in a shelter euthanizing 10 to 20 thousand 
animals a year. Furthermore, the investi-
gator compared the T -61 results with 
the results of a weak and marginally 
lethal dose of sodium pentobarbital. 
TABLE 1 Comparative Cost$ ofT-61 and Sodit~m Pentobarbital 
Unit Price Approx. Price 
Product Class* (1 bottle) Unit Price** (per 250 ml) 
T -61 Not schedule 50 ml $13.60 $68.00 
250 ml $55.00 $55.00 
Fatal-Plus 
a 
C-11 250 ml $14.00 $14.00 
Euthanasia-6 b C-11 100 ml $ 7.40 $18.50 
250 ml $14.40 $14.40 
Beuthanasia-Dc C-111 100 ml $22.50 $56.25 
a. Vortech Pharmaceuticals Limited, Dearborn, MI. Each milliliter contains: 390 mg of sodium pentobarbi-
tal (powder reconstituted with ordinary water) 
b. Veterinary Laboratories, Inc., Lenexa, KS. Each milliliter contains: 390 mg of sodium pentobarbital in an 
aqueous alcohol-propylene glycol base. 
c. Burns-Biotec Laboratories, Inc., Omaha, NE. Each milliliter contains: 390 mg of sodium pentobarbital, 
50 mg of phenytoin sodium, 10% of ethyl alcohol, 18% of propylene glycol, 0.003688 mg of rhodamine B 
(coloring) and 2% of benzil alcohol (preservative). 
*Classification of a restricted drug by the Bureau of Veterinary Medicine of the Food and Drug Administra-
tion of the U.S. (11) 
**These prices were obtained from the manufacturers. 
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The study was, thus, hardly a fair test. 
Anecdotal evidence indicates that, 
in practice, T -61 euthanasia can be as-
sociated with many problems. In addi-
tion, it has to be injected intravenously 
in a carefully controlled manner to 
achieve optimal results. It is totally 
unrealistic to expect that routine eu-
thanasia in a busy shelter will be able to 
keep to such a precise protocol which 
has only a small margin for error. 
At present, T -61 cannot be recom-
mended for routine practice when the 
more reliable, and apparently cheaper, 
alternative of sodium pentobarbital can 
be used. At best, T -61 should be used 
only as an emergency backup when the 
supplies of barbiturates have run out, 
and its use restricted to healthy animals 
that can easily be injected intravenously 
by an experienced person (7). 
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Legislation & Regulation 
Legislative Recognition of Animal 
Rights 
There have been several inquiries 
about legislation in California which 
recognizes that animals have rights. The 
state of California's resolution on this 
matter is here reprinted in its entirety. 
Senate Concurrent Resolution No. 8 
Resolution Chapter 99 
Senate Concurrent Resolution No. 8-
Relative to animal rights. 
[Filed with Secretary of State 
September 18, 1979.] 
LEGISLATIVE COUNSEL'S DIGEST 
SCR 8, Roberti. Animal rights. 
This measure states that the Legisla-
ture should take effective measures to 
protect and defend the rights of animals 
by enacting humane and environmental-
ly sound legislation . 
Whereas, The State of California 
has in the past led the country in passing 
legislation which recognizes the princi-
ple of animal rights; and 
Whereas, From childhood man should 
be taught to observe, understand, and 
respect animal life which is linked tore-
spect for mankind; and 
Whereas, To advance our civilization 
we must become aware of the rights of 
all animals; now, therefore, be it 
Resolved by the Senate of the State 
of California, the Assembly thereof con-
curring, That the Legislature of the State 
of California should take effective mea-
sures to protect and defend the rights of 
animals by enacting humane and environ-
mentally sound legislation. 
H.R. 3170: A Bill for Farm Animals 
Thanks to a bill introduced by Rep. 
james Howard (0-NJ), intensive farming 
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practices could get a close look from a 
Congressional Commission. 
On May 26, 1983, Rep. Howard intro-
duced his improved version of the Mottl 
bill from last Congress. The new bill was 
immediately referred to two House com-
mittees- a major strategic improve-
ment over the fate of the Mottl bill, 
which was referred to only one, the hos-
tile House Agriculture Committee. The 
Howard bill has again been referred to 
the Agricultural Committee, except this 
time the bill has also been given joint re-
ferral to the Health Subcommittee on 
the House Energy and Commerce Com-
mittee. Joint referral means that either 
Committee could initiate hearings with-
out having to wait for the other's timetable. 
For the first time in the history of 
the U.S. Congress, there could be a Com-
mission to look at intensive methods of 
livestock and poultry husbandry. 
Although Rep. Howard admits to be-
ing more interested in "the consumer 
end than the farmer end," H.R. 3170 
would establish a commission to study 
"intensive farm animal husbandry." How-
ard claims the suffering of the animals is 
shocking and that the effects of eating 
food produced through intensive confine-
mentis alarming. According to the most 
recent research, human beings are ex-
posed to health risks from antibiotics, as 
well as growth hormones such as DES 
and appetite stimulants such as arsenic, 
which are given to farm animals to boost 
profits and productivity. 
The Howard Commission would set 
in motion a well-balanced, hard look at 
modern intensive farming practices which 
is long overdue. Along with the consumer 
health issue, environmental issues would 
be examined, as well as the economic im-
pacts of intensive vs. alternative husbandry 
practices for the farmer, producer, and 
consumer. 
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